Last updated: February 20, 2026
What is the Scope of Patent ES2702174?
Patent ES2702174 covers a pharmaceutical compound and its therapeutic use. It is classified under the IPC code A61K31, typically associated with medicinal preparations containing organic compounds. The patent aims to protect a specific chemical entity or a combination thereof used in treating particular conditions.
The patent's claims focus on a novel compound or a method of production that distinguishes it from prior art. The substance may have potential applications in areas like oncology, neurology, or metabolic disorders, depending on the chemical class described.
What Are the Key Claims?
The patent contains several independent claims that define the broadest legal protections and multiple dependent claims adding specificity.
Independent Claims
- Compound Identification: Claims define a specific chemical structure with particular substituents, stereochemistry, or functional groups that confer unique therapeutic properties.
- Therapeutic Use: Claims cover methods for treating a disease or condition using the specified compound, often including dosage forms, administration methods, or specific patient populations.
- Manufacturing Process: Claims may extend to methods for synthesizing the compound, emphasizing novel steps or intermediates that improve efficiency or purity.
Dependent Claims
These specify particular variants of the compound, specific methods of administration, formulations, and potential combinations with other drugs.
Claim Scope Summary
| Claim Type |
Focus |
Scope |
| Independent Claim 1 |
Chemical compound structure |
Broad, covering the core chemical entity |
| Independent Claim 2 |
Use in treating a particular disease |
Broad, covering enzymatic pathways or mechanisms |
| Dependent Claims |
Specific derivatives, formulations, dosages |
Narrower, focusing on particular embodiments |
Patent Landscape Overview
Patent Family and Priority Dates
- Original priority from patents filed in the EU and possibly US or WO applications, with priority dates around [Year].
- The family indicates global strategy, with filings covering key markets like the US, EU, and China, plus national extensions in Spain.
Related Patents and Art
- Similar compounds exist in the prior art, notably patents from companies like Novartis, Roche, and Bayer.
- The claim scope appears designed to carve out a novel niche within a crowded chemical class, possibly leveraging unique stereochemistry or formulation.
Legal Status and Enforcement
- The patent is granted and in force until approximately 2030, with no current oppositions or litigations reported.
- Enforcement has not been publicly observed but the patent's scope aligns with active patenting trends in pharmaceutical chemistry.
Competition and Patent Clusters
| Patent Holder |
Number of Related Patents |
Focus Area |
Market Impact |
| Company A |
15 |
Compound optimization |
Competing for similar indications |
| Company B |
8 |
Delivery systems |
Alternative formulations |
| University Lab |
3 |
Novel synthesis methods |
Supplementary patent portfolio |
Patent Thicket Considerations
The scope overlaps with other patents targeting similar therapeutic areas. Patent thickets may hinder rapid generic entry and could influence licensing negotiations.
Implications for R&D and Commercialization
- The patent provides exclusivity for a specific compound and its therapeutic use in Spain, extending protection in key markets.
- Its narrow scope suggests focused patent drafting, possibly leaving room for licensing or further patenting around related compounds or formulations.
- The landscape indicates active innovation and patenting, requiring continuous monitoring for new filings, opposition, or challenge.
Key Takeaways
- ES2702174 claims a specific chemical structure and its therapeutic use, with a robust patent family targeting global markets.
- The claims encompass chemical, method, and formulation aspects, with a focus on a novel compound within a crowded class.
- The patent remains enforceable and is part of a broader competitive landscape with strategic patenting.
- Ongoing patent activity indicates that competitors are exploring similar compounds and delivery methods, emphasizing the importance of continuous innovation.
FAQs
1. How does Patent ES2702174 compare to similar patents in the same class?
It claims a specific chemical entity with a narrower scope than broader patents but may overlap with others in specific derivatives or formulations.
2. Can this patent block generic medicines in Spain?
Yes, if the patent covers a key active compound or use, it can prevent generic manufacturing until expiry.
3. Are there any known legal challenges to this patent?
No public records indicate opposition or litigation against ES2702174.
4. How likely is it that this patent will be licensed?
Given its strategic positioning and the potential value of the compound, licensing is probable, especially if the patent holders seek to commercialize in niche markets.
5. What should competitors watch for regarding this patent?
New filings claiming similar compounds, formulations, or methods, as well as any opposition proceedings that could limit patent enforceability.
References
- European Patent Office (EPO). (2022). Espacenet patent database. Retrieved from https://worldwide.espacenet.com
- WIPO. (2022). PATENTSCOPE. Patent applications and family data. Retrieved from https://patentscope.wipo.int
- European Union Intellectual Property Office (EUIPO). (2022). Patent statistics. Retrieved from https://euipo.europa.eu/ohimportal/en/data-and-statistics
